Conference Coverage (ICAAC)

Rotavirus Vaccine Reduces Hospitalizations

Published in Vaccine Weekly, October 28th, 1996

Vaccination against rotavirus can reduce potentially life-threatening episodes of severe diarrhea.

The finding is based on results from the largest-ever clinical trial of a rotavirus vaccine: the rhesus/human reassortant tetravalent RRV-TV vaccine manufactured by Wyeth-Ayerst Research.

"This study is the first to demonstrate that rotavirus vaccine prevents hospitalization in infants and provides strong support for public health value of rotavirus vaccination," reported Timo Vesikari of the University of Tampere, Finland.

Vesikari reported the study results in a late breaker session of the American Society for Microbiology's 36th...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1996-10-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry